Peel Hunt reiterated their buy rating on shares of Genus (LON:GNS) in a research report sent to investors on Wednesday morning, LSE.Co.UK reports. Peel Hunt currently has a GBX 3,200 ($41.81) price objective on the stock.
Several other research analysts have also recently weighed in on GNS. Stifel Nicolaus started coverage on Genus in a research note on Wednesday, May 29th. They set a hold rating and a GBX 2,685 ($35.08) target price for the company. Liberum Capital reaffirmed a buy rating on shares of Genus in a research note on Friday, September 6th. Finally, Peel Hunt reaffirmed a buy rating and set a GBX 3,200 ($41.81) target price on shares of Genus in a research note on Tuesday. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of GBX 2,819.17 ($36.84).
GNS stock traded down GBX 10 ($0.13) during trading hours on Wednesday, hitting GBX 2,880 ($37.63). 61,632 shares of the stock traded hands, compared to its average volume of 78,154. The stock has a 50-day simple moving average of GBX 2,615.60 and a 200 day simple moving average of GBX 2,501.11. Genus has a one year low of GBX 2,090 ($27.31) and a one year high of GBX 2,950 ($38.55). The company has a market cap of $1.87 billion and a P/E ratio of 242.02. The company has a current ratio of 2.01, a quick ratio of 1.19 and a debt-to-equity ratio of 21.92.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Story: Stock Portfolio Tracker
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.